ZYLORION Canadian Trademark Information

On Monday, October 4, 2021, a canadian trademark registration was filed for ZYLORION by PsiloTec Health Solutions Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 2137617. The current status of this trademark filing is Filing date accorded. The ZYLORION trademark is filed in the description of Psychedelic medicines for the treatment of psychiatric diseases, namely mood disorders, depression, mood and emotional instability disorders; psychedelic medicines for the treatment of addiction disorders, namely alcohol abuse, drug abuse, eating disorders, gambling addiction and sex addiction; psychedelic medicines for the treatment of anxiety disorders, namely social anxiety, generalized anxiety and panic attack disorder; psychedelic medicines for the treatment of psychological trauma, namely post-traumatic stress disorder, occupational stress injury, bullying, emotional trauma, physical trauma, work trauma, family violence and grief; psychedelic medicines for the treatment of physical trauma, namely post-burn injury, post-spinal-cord injury, adult post-amputation, post-brain injury and post-stroke; psychedelic medicines for the treatment of chronic pain, namely migraines, chronic back pain and chronic arthritis; psychedelic medicines for the treatment of cognitive diseases, namely cognitive deterioration, early dementia and age-associated memory impairment; psychedelic medicines for the treatment of neuropsychiatric disorders, namely adult fetal alcohol spectrum disorder, adult attention deficit disorder, adult autism, post-stroke symptoms, multiple sclerosis and Parkinson's disease; psychedelic medicines for the treatment of sleep related disorders, namely chronic fatigue syndrome, fatigue and insomnia; psychedelic medicines for the treatment of mental health problems experienced by indigenous and other marginalized communities; psychedelic medicines for the treatment of covid-19 symptoms and syndromes , Applications for mobile phones for providing therapy services to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; Downloadable computer software for providing therapy services to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes , Dried edible mushrooms , Fresh edible mushrooms , Compilation and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes , Provision of education and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education and training in the field of psychedelic medicines , Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; non-downloadable computer software for providing therapy services to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes , Psychotherapy services; therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services .